Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Use of PEP prophylaxis techniques may diverge from the evidence

Key clinical point: The adoption of techniques for post-ERCP pancreatitis (PEP) prophylaxis in clinical practice appears to deviate from the evidence.

Major finding: About 40% of endoscopists use rectal NSAIDs for patients at average risk of PEP.

Study details: A survey of 233 advanced endoscopists involved in fellowship training programs.

Disclosures: The authors did not report any study funding or disclosures.

Citation:

Avila P et al. Gastrointest Endosc. 2019 Nov 16. doi: 10.1016/j.gie.2019.11.013.